[1]
S. Tewari and R. Yadav, “A systematic review of reactivation of tuberculosis due to use of corticosteroids for COVID-19 treatment between January 2020 to January 2022”, Int J Basic Clin Pharmacol, vol. 11, no. 4, pp. 319–322, Jul. 2022.